speb/financial-data huggingface dataset:
XPO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 666000000.00
XPO income_statement (annual, 2022-12-31) — Net Interest Income: -135000000.00
XPO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 29000000.00
XPO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -1149000000.00
XPO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -1129000000.00
XPO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -135000000.00
XPO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 288000000.00
XPO balance_sheet (annual, 2022-12-31) — Net PPE: 2551000000.00
XPO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -433000000.00
XPO cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
XPO cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -20000000.00
XPO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -867000000.00
XPO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 319000000.00
XPO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 319000000.00
XPO income_statement (annual, 2022-12-31) — Normalized EBITDA: 936000000.00
XPO income_statement (annual, 2022-12-31) — Normalized Income: 291814000.00
XPO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 832000000.00
XPO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -60000000.00
XPO income_statement (annual, 2022-12-31) — Operating Income: 489000000.00
XPO income_statement (annual, 2022-12-31) — Operating Revenue: 7718000000.00
XPO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 115000000.00
XPO balance_sheet (annual, 2022-12-31) — Other Current Assets: 199000000.00
XPO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 59000000.00
XPO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 46000000.00
XPO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -222000000.00
XPO income_statement (annual, 2022-12-31) — Other Income Expense: -96000000.00
XPO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 407000000.00
XPO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 86000000.00
XPO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 209000000.00
XPO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 259000000.00
XPO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 55000000.00
XPO balance_sheet (annual, 2022-12-31) — Other Properties: 719000000.00
XPO income_statement (annual, 2022-12-31) — Other Special Charges: 39000000.00
XPO income_statement (annual, 2022-12-31) — Other Taxes: 58000000.00
XPO income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
XPO balance_sheet (annual, 2022-12-31) — Payables: 603000000.00
XPO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1295000000.00
XPO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
XPO cash_flow (annual, 2022-12-31) — Preferred Stock Payments: 0.00
XPO income_statement (annual, 2022-12-31) — Pretax Income: 258000000.00
XPO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -521000000.00
XPO balance_sheet (annual, 2022-12-31) — Receivables: 954000000.00
XPO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 6988000000.00
XPO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 392000000.00
XPO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1404000000.00
XPO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
XPO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 108000000.00
XPO balance_sheet (annual, 2022-12-31) — Retained Earnings: -4000000.00
XPO cash_flow (annual, 2022-12-31) — Sale Of Investment: 29000000.00
XPO cash_flow (annual, 2022-12-31) — Sale Of PPE: 88000000.00
XPO income_statement (annual, 2022-12-31) — Selling General And Administration: 183000000.00
XPO balance_sheet (annual, 2022-12-31) — Share Issued: 115000000.00
XPO income_statement (annual, 2022-12-31) — Special Income Charges: -151000000.00
XPO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 77000000.00
XPO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1012000000.00
XPO balance_sheet (annual, 2022-12-31) — Tangible Book Value: -867000000.00
XPO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -43186000.00
XPO income_statement (annual, 2022-12-31) — Tax Provision: 74000000.00
XPO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.29
XPO balance_sheet (annual, 2022-12-31) — Total Assets: 6269000000.00
XPO balance_sheet (annual, 2022-12-31) — Total Capitalization: 3485000000.00
XPO balance_sheet (annual, 2022-12-31) — Total Debt: 3245000000.00
XPO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1012000000.00
XPO income_statement (annual, 2022-12-31) — Total Expenses: 7229000000.00
XPO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 5257000000.00
XPO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 4639000000.00
XPO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 3750000000.00
XPO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 377000000.00
XPO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 82000000.00
XPO income_statement (annual, 2022-12-31) — Total Unusual Items: -151000000.00
XPO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -151000000.00
XPO balance_sheet (annual, 2022-12-31) — Working Capital: 123000000.00
XPO income_statement (annual, 2023-12-31) — +Operating Expense: 227000000.00
XPO income_statement (annual, 2023-12-31) — +Total Revenue: 7744000000.00
XPO balance_sheet (annual, 2023-12-31) — Accounts Payable: 532000000.00
XPO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 973000000.00
XPO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1853000000.00
XPO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1298000000.00
XPO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -45000000.00
XPO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
XPO balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 0.00
XPO income_statement (annual, 2023-12-31) — Basic Average Shares: 116000000.00
XPO income_statement (annual, 2023-12-31) — Basic EPS: 1.64
XPO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 470000000.00
XPO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 733000000.00
XPO cash_flow (annual, 2023-12-31) — Capital Expenditure: -1533000000.00
XPO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 709000000.00
XPO balance_sheet (annual, 2023-12-31) — Capital Stock: 0.00
XPO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 412000000.00
XPO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 412000000.00
XPO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 761000000.00
XPO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -1502000000.00
XPO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 694000000.00
XPO cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: 0.00
XPO cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: 3000000.00
XPO cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: -12000000.00
XPO cash_flow (annual, 2023-12-31) — Change In Account Payable: -48000000.00
XPO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 4000000.00
XPO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -9000000.00
XPO cash_flow (annual, 2023-12-31) — Change In Payable: -48000000.00
XPO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -44000000.00
XPO cash_flow (annual, 2023-12-31) — Change In Receivables: -46000000.00
XPO cash_flow (annual, 2023-12-31) — Change In Working Capital: -99000000.00
XPO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -46000000.00
XPO cash_flow (annual, 2023-12-31) — Changes In Cash: -56000000.00
XPO balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
XPO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1266000000.00
XPO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
XPO cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
XPO income_statement (annual, 2023-12-31) — Cost Of Revenue: 6974000000.00
XPO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 691000000.00
XPO balance_sheet (annual, 2023-12-31) — Current Assets: 1593000000.00
XPO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 121000000.00
XPO balance_sheet (annual, 2023-12-31) — Current Debt: 69000000.00
XPO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 190000000.00
XPO balance_sheet (annual, 2023-12-31) — Current Liabilities: 1590000000.00
XPO cash_flow (annual, 2023-12-31) — Deferred Income Tax: 31000000.00
XPO cash_flow (annual, 2023-12-31) — Deferred Tax: 31000000.00
XPO cash_flow (annual, 2023-12-31) — Depreciation: 432000000.00
XPO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 432000000.00
XPO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 432000000.00
XPO income_statement (annual, 2023-12-31) — Diluted Average Shares: 118000000.00
XPO income_statement (annual, 2023-12-31) — Diluted EPS: 1.60
XPO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 189000000.00
XPO income_statement (annual, 2023-12-31) — EBIT: 428000000.00
XPO income_statement (annual, 2023-12-31) — EBITDA: 860000000.00
XPO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 5000000.00
XPO balance_sheet (annual, 2023-12-31) — Employee Benefits: 91000000.00
XPO cash_flow (annual, 2023-12-31) — End Cash Position: 419000000.00
XPO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 761000000.00
XPO cash_flow (annual, 2023-12-31) — Free Cash Flow: -851000000.00
XPO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -5000000.00
XPO income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 5000000.00
XPO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -217000000.00
XPO income_statement (annual, 2023-12-31) — General And Administrative Expense: 167000000.00
XPO balance_sheet (annual, 2023-12-31) — Goodwill: 1498000000.00
XPO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1920000000.00
XPO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 1018000000.00
XPO balance_sheet (annual, 2023-12-31) — Gross PPE: 5636000000.00
XPO income_statement (annual, 2023-12-31) — Gross Profit: 770000000.00
XPO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
XPO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 34000000.00
XPO income_statement (annual, 2023-12-31) — Insurance And Claims: 167000000.00
XPO income_statement (annual, 2023-12-31) — Interest Expense: 168000000.00
XPO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 168000000.00
XPO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 185000000.00
XPO balance_sheet (annual, 2023-12-31) — Invested Capital: 4670000000.00
XPO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -1499000000.00
XPO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
XPO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 2996000000.00
XPO balance_sheet (annual, 2023-12-31) — Land And Improvements: 860000000.00
XPO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 588000000.00
XPO balance_sheet (annual, 2023-12-31) — Long Term Debt: 3335000000.00
XPO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 3923000000.00
XPO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 2962000000.00
XPO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2188000000.00
XPO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 859000000.00
XPO balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
XPO income_statement (annual, 2023-12-31) — Minority Interests: 0.00
XPO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
XPO balance_sheet (annual, 2023-12-31) — Net Debt: 2992000000.00
XPO income_statement (annual, 2023-12-31) — Net Income: 189000000.00
XPO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 189000000.00
XPO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 192000000.00
XPO income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -3000000.00
XPO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 189000000.00
XPO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 192000000.00
XPO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 189000000.00
XPO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 189000000.00
XPO income_statement (annual, 2023-12-31) — Net Interest Income: -168000000.00
XPO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 2000000.00
XPO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 808000000.00
XPO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 774000000.00
XPO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -168000000.00
XPO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -47000000.00
XPO balance_sheet (annual, 2023-12-31) — Net PPE: 3783000000.00
XPO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1504000000.00
XPO cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 34000000.00
XPO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -654000000.00
XPO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 337000000.00
XPO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 337000000.00
XPO income_statement (annual, 2023-12-31) — Normalized EBITDA: 990000000.00
XPO income_statement (annual, 2023-12-31) — Normalized Income: 288200000.00
XPO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 682000000.00
XPO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -5000000.00
XPO income_statement (annual, 2023-12-31) — Operating Income: 543000000.00
XPO income_statement (annual, 2023-12-31) — Operating Revenue: 7744000000.00
XPO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 115973170.00
XPO balance_sheet (annual, 2023-12-31) — Other Current Assets: 208000000.00
XPO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 69000000.00
XPO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 93000000.00
XPO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -217000000.00
XPO income_statement (annual, 2023-12-31) — Other Income Expense: -115000000.00
XPO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 422000000.00
XPO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 68000000.00
XPO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 196000000.00
XPO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 285000000.00
XPO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 15000000.00
XPO balance_sheet (annual, 2023-12-31) — Other Properties: 708000000.00
XPO income_statement (annual, 2023-12-31) — Other Special Charges: 33000000.00
XPO income_statement (annual, 2023-12-31) — Other Taxes: 60000000.00
XPO balance_sheet (annual, 2023-12-31) — Payables: 616000000.00
XPO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1307000000.00
XPO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
XPO income_statement (annual, 2023-12-31) — Pretax Income: 260000000.00
XPO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1533000000.00
XPO balance_sheet (annual, 2023-12-31) — Receivables: 973000000.00
XPO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 6974000000.00
XPO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 432000000.00
XPO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2188000000.00
XPO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
XPO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 102000000.00
XPO balance_sheet (annual, 2023-12-31) — Retained Earnings: 185000000.00
XPO cash_flow (annual, 2023-12-31) — Sale Of Investment: 2000000.00
XPO cash_flow (annual, 2023-12-31) — Sale Of PPE: 29000000.00
XPO income_statement (annual, 2023-12-31) — Selling General And Administration: 167000000.00
XPO balance_sheet (annual, 2023-12-31) — Share Issued: 115973170.00
XPO cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 34000000.00
XPO income_statement (annual, 2023-12-31) — Special Income Charges: -130000000.00
XPO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 78000000.00
XPO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1266000000.00
XPO balance_sheet (annual, 2023-12-31) — Tangible Book Value: -654000000.00
XPO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -33800000.00
XPO income_statement (annual, 2023-12-31) — Tax Provision: 68000000.00
XPO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.26
XPO balance_sheet (annual, 2023-12-31) — Total Assets: 7492000000.00
XPO balance_sheet (annual, 2023-12-31) — Total Capitalization: 4601000000.00
XPO balance_sheet (annual, 2023-12-31) — Total Debt: 4113000000.00
XPO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1266000000.00
XPO income_statement (annual, 2023-12-31) — Total Expenses: 7201000000.00
XPO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 6226000000.00
XPO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 5899000000.00
XPO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 4636000000.00
XPO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 438000000.00
XPO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 84000000.00
XPO income_statement (annual, 2023-12-31) — Total Unusual Items: -130000000.00
XPO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -130000000.00
XPO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
XPO balance_sheet (annual, 2023-12-31) — Working Capital: 3000000.00
XPO cash_flow (quarterly, 2024-09-30) — Cash From Discontinued Investing Activities: 0.00
XPO cash_flow (quarterly, 2024-09-30) — Cash From Discontinued Operating Activities: 0.00
XPO cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 39000000.00
XPO cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
XPO cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
XPO income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
XPO income_statement (annual, 2024-12-31) — +Operating Expense: 214000000.00
XPO income_statement (annual, 2024-12-31) — +Total Revenue: 8072000000.00
XPO balance_sheet (annual, 2024-12-31) — Accounts Payable: 477000000.00
XPO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 977000000.00
XPO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -2019000000.00
XPO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1274000000.00
XPO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -50000000.00
XPO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
XPO income_statement (annual, 2024-12-31) — Basic Average Shares: 116000000.00
XPO income_statement (annual, 2024-12-31) — Basic EPS: 3.33
XPO income_statement (quarterly, 2024-12-31) — Basic EPS: 0.65
XPO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 419000000.00
XPO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 874000000.00
XPO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 874000000.00
XPO cash_flow (annual, 2024-12-31) — Capital Expenditure: -789000000.00
XPO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 730000000.00
XPO balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
XPO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 246000000.00
XPO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 246000000.00
XPO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -226000000.00
XPO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -702000000.00
XPO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 808000000.00
XPO cash_flow (annual, 2024-12-31) — Cash From Discontinued Financing Activities: 0.00
XPO cash_flow (annual, 2024-12-31) — Cash From Discontinued Investing Activities: 0.00
XPO cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Investing Activities: 0.00
XPO cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: 0.00
XPO cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Operating Activities: 0.00
XPO cash_flow (annual, 2024-12-31) — Change In Account Payable: -8000000.00
XPO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -33000000.00
XPO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -106000000.00
XPO cash_flow (annual, 2024-12-31) — Change In Payable: -8000000.00
XPO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -41000000.00
XPO cash_flow (annual, 2024-12-31) — Change In Receivables: -47000000.00
XPO cash_flow (annual, 2024-12-31) — Change In Working Capital: -194000000.00
XPO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -47000000.00
XPO cash_flow (annual, 2024-12-31) — Changes In Cash: -121000000.00
XPO balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
XPO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1600000000.00
XPO cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
XPO income_statement (annual, 2024-12-31) — Cost Of Revenue: 7157000000.00
XPO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 615000000.00
XPO balance_sheet (annual, 2024-12-31) — Current Assets: 1505000000.00
XPO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 127000000.00
XPO balance_sheet (annual, 2024-12-31) — Current Debt: 62000000.00
XPO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 189000000.00
XPO balance_sheet (annual, 2024-12-31) — Current Liabilities: 1420000000.00
XPO cash_flow (annual, 2024-12-31) — Deferred Income Tax: 57000000.00
XPO cash_flow (annual, 2024-12-31) — Deferred Tax: 57000000.00
XPO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 490000000.00
XPO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 490000000.00
XPO income_statement (annual, 2024-12-31) — Diluted Average Shares: 120000000.00
XPO income_statement (annual, 2024-12-31) — Diluted EPS: 3.23
XPO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 387000000.00
XPO income_statement (annual, 2024-12-31) — EBIT: 696000000.00
XPO income_statement (annual, 2024-12-31) — EBITDA: 1186000000.00
XPO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
XPO balance_sheet (annual, 2024-12-31) — Employee Benefits: 85000000.00
XPO cash_flow (annual, 2024-12-31) — End Cash Position: 298000000.00
XPO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -226000000.00
XPO cash_flow (annual, 2024-12-31) — Free Cash Flow: 19000000.00
XPO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -40000000.00
XPO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 40000000.00
XPO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -246000000.00
XPO income_statement (annual, 2024-12-31) — General And Administrative Expense: 134000000.00
XPO balance_sheet (annual, 2024-12-31) — Goodwill: 1461000000.00
XPO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1821000000.00
XPO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 1027000000.00
XPO balance_sheet (annual, 2024-12-31) — Gross PPE: 6150000000.00
XPO income_statement (annual, 2024-12-31) — Gross Profit: 915000000.00
XPO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
XPO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 90000000.00
XPO cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 19000000.00
XPO income_statement (annual, 2024-12-31) — Insurance And Claims: 134000000.00
XPO income_statement (annual, 2024-12-31) — Interest Expense: 223000000.00
XPO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 223000000.00
XPO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 223000000.00
XPO balance_sheet (annual, 2024-12-31) — Invested Capital: 4987000000.00
XPO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -702000000.00
XPO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
XPO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
XPO balance_sheet (annual, 2024-12-31) — Land And Improvements: 879000000.00
XPO balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 879000000.00
XPO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 603000000.00
XPO balance_sheet (annual, 2024-12-31) — Long Term Debt: 3325000000.00
XPO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 3928000000.00
XPO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
XPO cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
XPO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -82000000.00
XPO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 924000000.00
XPO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 924000000.00
XPO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
XPO balance_sheet (annual, 2024-12-31) — Net Debt: 3141000000.00
XPO income_statement (annual, 2024-12-31) — Net Income: 387000000.00
XPO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 387000000.00
XPO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 387000000.00
XPO income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 0.00
XPO income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
XPO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 387000000.00
XPO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 387000000.00
XPO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 387000000.00
XPO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 387000000.00
XPO income_statement (annual, 2024-12-31) — Net Interest Income: -223000000.00
XPO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 12000000.00
XPO cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 4000000.00
XPO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -91000000.00
XPO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -82000000.00
XPO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -223000000.00
XPO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -135000000.00
XPO balance_sheet (annual, 2024-12-31) — Net PPE: 4131000000.00
XPO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -714000000.00
XPO cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -9000000.00
XPO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -221000000.00
XPO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 393000000.00
XPO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 393000000.00
XPO income_statement (annual, 2024-12-31) — Normalized EBITDA: 1226000000.00
XPO income_statement (annual, 2024-12-31) — Normalized Income: 419760000.00
XPO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 808000000.00
XPO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -40000000.00
XPO income_statement (annual, 2024-12-31) — Operating Income: 701000000.00
XPO income_statement (annual, 2024-12-31) — Operating Revenue: 8072000000.00
XPO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 117174000.00
XPO balance_sheet (annual, 2024-12-31) — Other Current Assets: 282000000.00
XPO balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 62000000.00
XPO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 46000000.00
XPO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -246000000.00
XPO income_statement (annual, 2024-12-31) — Other Income Expense: -3000000.00
XPO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 360000000.00
XPO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 21000000.00
XPO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 254000000.00
XPO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 285000000.00
XPO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 37000000.00
XPO balance_sheet (annual, 2024-12-31) — Other Properties: 727000000.00
XPO income_statement (annual, 2024-12-31) — Other Taxes: 80000000.00
XPO balance_sheet (annual, 2024-12-31) — Payables: 570000000.00
XPO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1185000000.00
XPO income_statement (annual, 2024-12-31) — Pretax Income: 473000000.00
XPO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -789000000.00
XPO balance_sheet (annual, 2024-12-31) — Receivables: 977000000.00
XPO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 7157000000.00
XPO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 490000000.00
XPO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -82000000.00
XPO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
XPO income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 80000000.00
XPO balance_sheet (annual, 2024-12-31) — Retained Earnings: 572000000.00
XPO cash_flow (annual, 2024-12-31) — Sale Of Investment: 12000000.00
XPO cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 4000000.00
XPO cash_flow (annual, 2024-12-31) — Sale Of PPE: 75000000.00
XPO income_statement (annual, 2024-12-31) — Selling General And Administration: 134000000.00
XPO balance_sheet (annual, 2024-12-31) — Share Issued: 117174000.00
XPO income_statement (annual, 2024-12-31) — Special Income Charges: -40000000.00
XPO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 87000000.00
XPO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1600000000.00
XPO balance_sheet (annual, 2024-12-31) — Tangible Book Value: -221000000.00
XPO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -7240000.00
XPO income_statement (annual, 2024-12-31) — Tax Provision: 86000000.00
XPO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.18
XPO balance_sheet (annual, 2024-12-31) — Total Assets: 7712000000.00
XPO balance_sheet (annual, 2024-12-31) — Total Capitalization: 4925000000.00
XPO balance_sheet (annual, 2024-12-31) — Total Debt: 4117000000.00
XPO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1601000000.00
XPO income_statement (annual, 2024-12-31) — Total Expenses: 7371000000.00
XPO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 6111000000.00
XPO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 6206000000.00
XPO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 4691000000.00
XPO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 660000000.00
XPO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 93000000.00
XPO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 93000000.00
XPO income_statement (annual, 2024-12-31) — Total Unusual Items: -40000000.00
XPO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -40000000.00
XPO balance_sheet (annual, 2024-12-31) — Working Capital: 85000000.00
XPO income_statement (quarterly, 2025-03-31) — +Operating Expense: 54000000.00
XPO income_statement (quarterly, 2025-03-31) — +Total Revenue: 1954000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 501000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1083000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2113000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1227000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -49000000.00
XPO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 117000000.00
XPO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.59
XPO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 298000000.00
XPO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -199000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 714000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
XPO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 212000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 212000000.00
XPO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -30000000.00
XPO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -191000000.00
XPO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 142000000.00
XPO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -7000000.00
XPO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 35000000.00
XPO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 1000000.00
XPO cash_flow (quarterly, 2025-03-31) — Change In Payable: -7000000.00
XPO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 28000000.00
XPO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -107000000.00
XPO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -78000000.00
XPO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -107000000.00
XPO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -78000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
XPO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1640000000.00
XPO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
XPO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1747000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 758000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Current Assets: 1580000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 131000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Current Debt: 61000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 192000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1551000000.00
XPO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 4000000.00
XPO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 4000000.00
XPO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 123000000.00
XPO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 123000000.00
XPO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 120000000.00
XPO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.58
XPO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 69000000.00
XPO income_statement (quarterly, 2025-03-31) — EBIT: 147000000.00
XPO income_statement (quarterly, 2025-03-31) — EBITDA: 270000000.00
XPO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 85000000.00
XPO cash_flow (quarterly, 2025-03-31) — End Cash Position: 221000000.00
XPO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -30000000.00
XPO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -57000000.00
XPO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -2000000.00
XPO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 2000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -228000000.00
XPO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 35000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Goodwill: 1491000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1841000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1132000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6361000000.00
XPO income_statement (quarterly, 2025-03-31) — Gross Profit: 207000000.00
XPO income_statement (quarterly, 2025-03-31) — Insurance And Claims: 35000000.00
XPO income_statement (quarterly, 2025-03-31) — Interest Expense: 56000000.00
XPO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 56000000.00
XPO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 42000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 5037000000.00
XPO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -191000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 583000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 3336000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3919000000.00
XPO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -18000000.00
XPO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
XPO balance_sheet (quarterly, 2025-03-31) — Net Debt: 3185000000.00
XPO income_statement (quarterly, 2025-03-31) — Net Income: 69000000.00
XPO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 69000000.00
XPO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 69000000.00
XPO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 69000000.00
XPO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 69000000.00
XPO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 69000000.00
XPO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 69000000.00
XPO income_statement (quarterly, 2025-03-31) — Net Interest Income: -56000000.00
XPO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
XPO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 20000000.00
XPO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -18000000.00
XPO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -56000000.00
XPO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -50000000.00
XPO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Net PPE: 4248000000.00
XPO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -192000000.00
XPO cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 38000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -201000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 392000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 392000000.00
XPO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 277000000.00
XPO income_statement (quarterly, 2025-03-31) — Normalized Income: 74307692.31
XPO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 142000000.00
XPO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -2000000.00
XPO income_statement (quarterly, 2025-03-31) — Operating Income: 153000000.00
XPO income_statement (quarterly, 2025-03-31) — Operating Revenue: 1954000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 117788000.00
XPO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 285000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 61000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 100000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -228000000.00
XPO income_statement (quarterly, 2025-03-31) — Other Income Expense: -6000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 350000000.00
XPO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 11000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 210000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 292000000.00
XPO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Other Properties: 6361000000.00
XPO income_statement (quarterly, 2025-03-31) — Other Special Charges: -6000000.00
XPO income_statement (quarterly, 2025-03-31) — Other Taxes: 19000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Payables: 501000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1259000000.00
XPO income_statement (quarterly, 2025-03-31) — Pretax Income: 91000000.00
XPO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
XPO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -199000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Receivables: 1083000000.00
XPO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1747000000.00
XPO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 123000000.00
XPO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -18000000.00
XPO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
XPO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 15000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 641000000.00
XPO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 7000000.00
XPO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 35000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Share Issued: 117788000.00
XPO income_statement (quarterly, 2025-03-31) — Special Income Charges: -7000000.00
XPO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 15000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1640000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -201000000.00
XPO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -1692307.69
XPO income_statement (quarterly, 2025-03-31) — Tax Provision: 22000000.00
XPO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
XPO balance_sheet (quarterly, 2025-03-31) — Total Assets: 7879000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4976000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Total Debt: 4111000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1640000000.00
XPO income_statement (quarterly, 2025-03-31) — Total Expenses: 1801000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 6239000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 6299000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4688000000.00
XPO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 151000000.00
XPO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -7000000.00
XPO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -7000000.00
XPO balance_sheet (quarterly, 2025-03-31) — Working Capital: 29000000.00
XPO income_statement (quarterly, 2025-06-30) — +Operating Expense: 61000000.00
XPO income_statement (quarterly, 2025-06-30) — +Total Revenue: 2080000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 498000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1132000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2219000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1233000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -46000000.00
XPO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 118000000.00
XPO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 221000000.00
XPO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -196000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 760000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
XPO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 225000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 225000000.00
XPO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -44000000.00
XPO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -191000000.00
XPO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 247000000.00
XPO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -15000000.00
XPO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -9000000.00
XPO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 25000000.00
XPO cash_flow (quarterly, 2025-06-30) — Change In Payable: -15000000.00
XPO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -24000000.00
XPO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -17000000.00
XPO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -16000000.00
XPO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -17000000.00
XPO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 11000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
XPO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1781000000.00
XPO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -10000000.00
XPO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1812000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 777000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Current Assets: 1623000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 148000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Current Debt: 63000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 211000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1599000000.00
XPO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 2000000.00
XPO cash_flow (quarterly, 2025-06-30) — Deferred Tax: 2000000.00
XPO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 131000000.00
XPO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 131000000.00
XPO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 119000000.00
XPO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.89
XPO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 106000000.00
XPO income_statement (quarterly, 2025-06-30) — EBIT: 199000000.00
XPO income_statement (quarterly, 2025-06-30) — EBITDA: 330000000.00
XPO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 1000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 85000000.00
XPO cash_flow (quarterly, 2025-06-30) — End Cash Position: 233000000.00
XPO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -44000000.00
XPO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 51000000.00
XPO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -1000000.00
XPO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 1000000.00
XPO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -199000000.00